Stratus Medical is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.
Our foundational technology, the NIMBUS® RF Multitined Expandable Electrode, was invented by an interventional pain physician seeking to overcome anatomical variability when targeting nerves. By creating a large-volume RF lesion, NIMBUS helps reduce uncertainty and supports more consistent, reproducible, and sustained pain relief. NIMBUS is easy to use, compatible with existing RF generators, and designed to help lower overall procedure costs for hospitals and ambulatory surgery centers.
NIMBUS has been validated in multiple independent clinical studies, with several prospective, Level I trials currently enrolling patients.
NIMBUS was FDA cleared in 2012, and CE Marked (including the Vesta® RF system), in 2021. Today, NIMBUS is available in six countries and is rapidly expanding.
Stratus Medical will continue to innovate and deliver new products to market, including an RF Generator (currently under development and not FDA cleared).
The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA.
Stratus Medical is making constant efforts to improve the accessibility of its site and services in the belief that it is our collective moral obligation to allow seamless, accessible, and unhindered use for those of us with disabilities.
We aim to make all pages and content on stratusmedical.com accessible, but some content may not yet fully meet the highest accessibility standards. This could be due to challenges in identifying the most suitable technological solution.
We may revise this Statement periodically to reflect improvements or changes to our accessibility practices.
English English 
Italiano
Português do Brasil
Português
Español
العربية
Fundo:
A neurotomia por radiofrequência (RFN) pode ser um tratamento eficaz para pacientes com dor cervical crônica e cefaleias cervicogênicas resistentes ao tratamento conservador. No entanto, o grau e a duração do alívio da dor após a RFN dependem do grau de coagulação do nervo alvo.
Relato de caso:
Este é o caso de um paciente de 37 anos com dor cervical debilitante e dores de cabeça após um acidente automobilístico. O bloqueio anestésico local bem-sucedido do terceiro nervo occipital (TON) confirmou a dor de origem na articulação facetária C2-C3. Um tratamento inicial de RFN do TON, usando eletrodos 18G padrão no modo bipolar, resultou em melhora completa dos sintomas por 8 meses. A repetição do RFN, usando a mesma configuração de eletrodos, não foi bem-sucedida no alívio da dor severa no pescoço e das dores de cabeça, e não produziu nenhuma perda sensorial demonstrável na distribuição do TON. O RFN foi então realizado com o eletrodo expansível multitinado de RF eletrocirúrgico NIMBUS®, que proporciona uma zona de coagulação maior em volume do que os eletrodos de RFN padrão, mesmo quando usado em configuração bipolar.
Conclusão:
The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.
